Neimeth International Pharmaceuticals Plc (NGX: NEIMETH)

NGX: NEIMETH Ratios and Metrics

Market cap in millions NGN. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jan 29, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Sep 30, 2021	Sep 30, 2020
Market Capitalization	12,435	9,785	8,290	2,716	3,324	3,513
Market Cap Growth	18.04%	18.04%	205.24%	-18.29%	-5.41%	362.50%
Enterprise Value	15,605	11,901	9,264	5,237	5,412	5,187
Last Close Price	2.91	2.29	1.94	1.43	1.68	1.72
PE Ratio	-	-	-	-	12.28	16.54
PS Ratio	2.77	2.19	3.75	0.93	1.09	1.24
PB Ratio	-42.56	-42.56	5.64	3.49	2.35	2.76
P/TBV Ratio	-	-	5.64	3.49	2.35	2.76
P/FCF Ratio	7.86	6.19	-	-	1693.08	-
P/OCF Ratio	4.28	4.28	-	20.49	9.60	11.61
EV/Sales Ratio	3.49	2.66	4.19	1.79	1.78	1.83
EV/EBITDA Ratio	12.58	9.60	-	54.54	8.47	6.41
EV/EBIT Ratio	14.07	10.73	-	-	9.86	7.43
EV/FCF Ratio	9.87	7.52	-	-	2756.94	-
Debt / Equity Ratio	-22.08	-22.08	2.87	4.68	2.15	2.59
Debt / EBITDA Ratio	4.09	4.09	-	35.20	4.64	4.08
Debt / FCF Ratio	3.21	3.21	-	-	1551.72	-
Asset Turnover	0.47	0.47	0.29	-	0.48	0.62
Inventory Turnover	1.21	1.21	0.79	-	1.12	1.22
Quick Ratio	0.36	0.36	0.43	0.48	1.53	1.64
Current Ratio	0.59	0.59	0.75	1.00	2.28	2.34
Return on Equity (ROE)	-274.21%	-274.21%	-254.91%	-	20.13%	18.11%
Return on Assets (ROA)	7.36%	7.36%	-6.22%	-	5.41%	9.53%
Return on Capital (ROIC)	13.17%	13.17%	-9.51%	-	7.60%	13.13%
Earnings Yield	-13.67%	-17.37%	-34.56%	-11.97%	8.14%	6.05%
FCF Yield	12.72%	16.16%	-20.62%	-41.87%	0.06%	-7.44%
Dividend Yield	0.00%	-	-	-	4.16%	3.78%
Payout Ratio	0.00%	-	-	-	45.62%	-
Buyback Yield / Dilution	0.58%	0.58%	-125.00%	-	-	-
Total Shareholder Return	0.58%	0.58%	-125.00%	-	4.16%	3.78%

Source: S&P Capital IQ. Standard template. Financial Sources.